275 related articles for article (PubMed ID: 30976973)
1. Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes.
Reyes JF; Sackmann C; Hoffmann A; Svenningsson P; Winkler J; Ingelsson M; Hallbeck M
Acta Neuropathol; 2019 Jul; 138(1):23-47. PubMed ID: 30976973
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein transfers from neurons to oligodendrocytes.
Reyes JF; Rey NL; Bousset L; Melki R; Brundin P; Angot E
Glia; 2014 Mar; 62(3):387-98. PubMed ID: 24382629
[TBL] [Abstract][Full Text] [Related]
5. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R
PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
7. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.
Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M
Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820
[TBL] [Abstract][Full Text] [Related]
9. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
[TBL] [Abstract][Full Text] [Related]
10. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
[TBL] [Abstract][Full Text] [Related]
11. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.
Spencer B; Valera E; Rockenstein E; Trejo-Morales M; Adame A; Masliah E
Mol Neurodegener; 2015 Sep; 10():48. PubMed ID: 26394760
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.
Paleologou KE; Oueslati A; Shakked G; Rospigliosi CC; Kim HY; Lamberto GR; Fernandez CO; Schmid A; Chegini F; Gai WP; Chiappe D; Moniatte M; Schneider BL; Aebischer P; Eliezer D; Zweckstetter M; Masliah E; Lashuel HA
J Neurosci; 2010 Mar; 30(9):3184-98. PubMed ID: 20203178
[TBL] [Abstract][Full Text] [Related]
13. The neuropathology of multiple system atrophy and its therapeutic implications.
Valera E; Masliah E
Auton Neurosci; 2018 May; 211():1-6. PubMed ID: 29169744
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
15. Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.
Grigoletto J; Pukaß K; Gamliel A; Davidi D; Katz-Brull R; Richter-Landsberg C; Sharon R
Acta Neuropathol Commun; 2017 May; 5(1):37. PubMed ID: 28482862
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
[TBL] [Abstract][Full Text] [Related]
17. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.
Nakayama K; Suzuki Y; Yazawa I
Am J Pathol; 2009 Apr; 174(4):1471-80. PubMed ID: 19286568
[TBL] [Abstract][Full Text] [Related]
18. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
Stemberger S; Poewe W; Wenning GK; Stefanova N
Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.
Valera E; Ubhi K; Mante M; Rockenstein E; Masliah E
Glia; 2014 Feb; 62(2):317-37. PubMed ID: 24310907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
